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Methods: In 102 patients, mean age 72±9 years (males 78), mean LVEF 31±7%,
LV electrical delay (Q-LV) and contractility response (during biventricular pac-
ing) were systematically measured at each available pacing site. Contractility was
measured as variations of LV dP/dtmax by means of a RADI pressure wire. The
LV anatomy was divided into 15 portions. In the right anterior oblique (RAO) view,
the long axis of the heart was divided into basal, mid, and apical ventricular seg-
ments. In the left anterior oblique (LAO) view, the short axis of the heart was di-
vided into anterior, anterolateral, lateral, postero-lateral and posterior segments.
Results: A total of 294 veins and 616 sites were tested. On average, the basal
portion of the lateral vein showed the largest electrical delay (Q-LV 124.9±34.2
ms) and the highest hemodynamic response (increase in dP/dtmax 24.8±15.5%
vs baseline). In 36/102 patients (35.3%) the basal lateral was the optimal site for
LV lead. In 8/102 patients (7.8%) the apical region (4/102 lateral, 4/102 postero-
lateral) was classified as the optimal site.
All tested sites and best sites
Conclusion: Analyzing systematically the electrical delay and the hemodynamic
response to biventricular pacing in all the available veins we observed in 8% of
cases the apical region as the optimal site for LV lead positioning.
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Background: Atrial tachyarrhythmias (ATAs) have a significant negative impact
on the prognosis in patients implanted with a cardiac resynchronization therapy
(CRT). A new-generation atrial antitachycardia pacing (Reactive ATP) was re-
ported to be effective for the management of ATAs in patients implanted with a
pacemaker.
Purpose: The purpose of this study was to evaluate the efficacy and safety of
Reactive ATP in patients implanted with a CRT.
Methods: This study included 128 patients who were implanted with a CRT capa-
ble of Reactive ATP (Reactive ATP group) (90 males, mean age: 61.9±14.9 years,
mean left ventricular ejection fraction (LVEF): 29.2±11.5%).and 62 patients (51
males, mean age: 70.8±11.4, mean LVEF: 27.8±10.5%) who were implanted with
a CRT without ATP function (Control group). The clinical outcome was compared
between the 2 groups.
Results: At baseline, 44 patients (34%) in the Reactive ATP group had a his-
tory of ATA. During 3 months after Reactive ATP was programmed, 96 of 265
ATA episodes (36.2%) were successfully terminated by Reactive ATP (median
success rate 34.8%). After Reactive ATP was programed, there was a significant
decrease in atrial fibrillation (AF) burden (9.4±15.9% to 1.5±2.7%, p=0.021) and
increase in biventricular (BiV) pacing rate (95.3±4.7% to 97.5±2.4%, p=0.016).
During 743±357 days of follow-up period, 39 patients (30%) experienced a total
of 3207 ATA episodes (median success rate 33.3%). No ventricular arrhythmias
were induced by Reactive ATP. The clinical outcome was compared between age-
matched patients who had a history of ATAs in the Reactive ATP group (15 males,
mean age: 69.2±9.2 years) and those in the Control group (20 males, mean age:
69.4±9.1 years). Patients in the Reactive ATP group showed a significant lower
incidence of heart failure (HF) hospitalization compared with those in the control
group (P=0.043). There were no significant differences in the incidence of cardiac
death and progression to permanent AF between the two groups.
Conclusions: Reactive ATP reduced AF burden and increased BiV pacing rate
in patients implanted with a CRT. Especially in patients with a history of ATAs, the
risk of HF hospitalization was significantly reduced by Reactive ATP. These data
support the efficacy and safety of Reactive ATP in patients implanted with a CRT.
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Introduction: The most recent studies in cardiac resynchronization therapy
(CRT) have been focused on attempts to improve response rate, such as the
determination of the optimal placement of the left ventricular (LV) lead. The po-
sition of the LV lead guided by the site of latest electrical delay (ED), seems to
be a promising strategy. The same strategy may be useful in assessing the ideal
positioning of right ventricular (RV) lead in CRT.
Purpose: To determine the most favorable position of the RV lead (septal versus
apical) in CRT, by measuring the ED of the LV poles during septal or apical RV
pacing in patients with triple-site CRT (TRIV).
Methods: A single-center prospective study of consecutive patients (Oct. 2014
to Oct. 2017) submited to CRT device implantation (Quadra Allure MPTM, which
allows post-implantation ED measurement) in TRIV mode - with a quadripolar
lead in the LV, a RV lead positioned at the septum and a RV lead at the apex.
In the follow-up, the lead position was confirmed and determined by fluoroscopic
evaluation (anterior, lateral and postero-lateral in the short axis and basal, mid
and apical on the long axis). The ED was measured at the 4-pole LV lead, during
apical and septal RV pacing and the relation between the ED and lead position
was evaluated.
Results: Twenty two patients were included: 82% male, median age 78 years;
50% implanted CRT with defibrillator; 27% had ischemic heart disease and 73%
non-ischemic etiology; all patients had permanent atrial fibrillation and the QRS
duration was of 176±29ms. The position of the LE lead poles was classified as
lateral in 44% and postero-lateral in 56%, basal in 28%, medial in 39% and apical
in 34%. We evaluated 160 ED. The mean ED between the apical RV lead and the
LV poles was significantly higher than the delay between septal RV lead and the
LV poles [161±33ms vs 75±45ms (p<0.001)]. This difference remained significant
in LV poles located in a lateral position (76±62 vs. 166±36ms; p<0.001) or in a
postero-lateral position (74±30 vs. 157±31ms; p<0.001); the same ocurred for
LV poles in a basal (99±62 vs. 179±24ms, p<0.001), mid (72±38 vs. 167±31ms,
p<0.001) and apical location (57±24 vs. 140±32ms, p<0.001).
Conclusion: The LV lead position is an important determinant of the success
of CRT, but is conditioned by anatomical and technical characteristics. The op-
timization of CRT may then depend on the positioning of RV lead. This study
demonstrated that the apical (vs. septal) RV lead positioning presents higher ED
in relation to LV lead, regardless of the latter position.
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ICRC, Brno, Czech Republic; 2Institute of Scientific Instruments, ASCR, Brno,
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Introduction: Electrical depolarization is an initiating point for mechanical action
of myocardium. The temporal and spatial distribution of the ventricular electrical
depolarization can be assessed by processing of higher frequencies in the QRS
complex using only standard 12-lead setup.
Purpose: The purpose of the study was to demonstrate that the dyssynchronous
electrical depolarization assessed by surface 12-lead ECG in LBBB patients can
be compared with initiation of mechanical action of left ventricle (LV) myocardium
assessed by Speckle Tracking Echocardiography (STE).
Methods: 23 dilated cardiomyopathy patients (5 females) with LBBB indicated
for cardiac resynchronization therapy (CRT) were measured using 12-lead ECG
with higher sampling frequency and bit resolution (5kHz / 24bits) for 5 min. The
averaged V1-V6 QRS envelopes in frequency range 500–1000Hz were calcu-
lated. The electrical depolarization dyssynchrony was assessed as a difference
between soonest and latest activation in V leads. The mechanical dyssynchrony
was evaluated analogically from STE.
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